SCHEMBL4737640

SCHEMBL4737640

O=C(Nc1sc(-c2ccccc2)nc1-c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.63
MAPT P10636 3/20 0.63
ALDH1A1 P00352 2/20 0.63
SMN1; SMN2 Q16637 4/20 0.62
NPC1 O15118 4/20 0.62
RAB9A P51151 4/20 0.62
HTT P42858 3/20 0.60
GAA P10253 1/20 0.60
KMT2A Q03164 3/20 0.58
NPSR1 Q6W5P4 1/20 0.58
RXFP1 Q9HBX9 1/20 0.58
CYP1A2 P05177 1/20 0.55
POLB P06746 1/20 0.55
HSP90AA1 P07900 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
CYP2C19 P33261 1/20 0.55
CCR6 P51684 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4738310 0.90 ALDH1A1 (0.71) KDM4EMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL4737623 0.87 KDM4E (0.60) KDM4EMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL4737628 0.85 KDM4E (0.64) KDM4EMAPTALDH1A1SMN1; SMN2HTT
SCHEMBL4741747 0.84 MEN1 (0.65) KDM4EMAPTALDH1A1NPC1RAB9A
SCHEMBL4268936 0.80 KDM4E (0.77) KDM4EMAPTALDH1A1SMN1; SMN2GAA
SCHEMBL4737632 0.80 KDM4E (0.62) KDM4EMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL14148402 0.79 KDM4E (0.61) KDM4EMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL4740896 0.78 LMNA (0.56) KDM4EMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL14148384 0.77 KDM4E (0.73) KDM4EMAPTALDH1A1SMN1; SMN2GAA
SCHEMBL14148528 0.77 KDM4E (0.68) KDM4EMAPTALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008090382-A1 THIAZOLE AND OXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PRION DISEASES, CANCER AND CONDITIONS OF THE CENTRAL NERVOUS SYSTEM AS WELL AS IN THE REGULATION OF STEM CELLS THE UNIVERSITY OF SHEFFIELD (GB) 2008-07-31 WO disclosed